Your account is not claimed yet. You can sign up with ORCID to claim your account.

Marjukka Anttila (M Anttila)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 7

Top Venues

Finnish Food Authority

Cornell University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Finnish Food Authority Apr 1o 1988

Finland

Professor :: Pathology

Education History

Cornell University Sep 1o 1983 - Mar 31o 1988

United States

PHD :: Pathology

Publications

Dafne C A Quixabeira, E Jirovec, S Pakola, R Havunen, S Basnet, J M Santos, Tatiana Viktorovna Kudling, J H A Clubb, L Haybout, V Arias, S Grönberg-Vähä-Koskela, V Cervera-Carrascon, Annukka Pasanen, Marjukka Anttila, J Tapper, A Kanerva, Akseli E Hemminki
Improving the cytotoxic response of tumor-infiltrating lymphocytes towards advanced stage ovarian cancer with an oncolytic adenovirus expressing a human vIL-2 cytokine. Cancer gene therapy (2023)
Dafne C A Quixabeira, S Pakola, E Jirovec, R Havunen, S Basnet, J M Santos, Tatiana Viktorovna Kudling, J H A Clubb, L Haybout, V Arias, S Grönberg-Vähä-Koskela, V Cervera-Carrascon, Erja Kerkelä, Annukka Pasanen, Marjukka Anttila, J Tapper, A Kanerva, Akseli E Hemminki
Boosting cytotoxicity of adoptive allogeneic NK cell therapy with an oncolytic adenovirus encoding a human vIL-2 cytokine for the treatment of human ovarian cancer. Cancer gene therapy (2023)
Dafne C A Quixabeira, Victor Cervera-Carrascon, Joao M Santos, James H A Clubb, Tatiana Viktorovna Kudling, Saru Basnet, Camilla Heiniö, Susanna Grönberg-Vähä-Koskela, Marjukka Anttila, Riikka Havunen, Anna Kanerva, Akseli E Hemminki
Local therapy with an engineered oncolytic adenovirus enables antitumor response in non-injected melanoma tumors in mice treated with aPD-1. Oncoimmunology 11 (1) (2022)
Marjo K Hytönen, Riika Sarviaho, Christopher B Jackson, Pernilla Syrjä, Tarja S Jokinen, Kaspar Matiasek, Marco Rosati, Cristina Dallabona, Enrico Baruffini, Ileana Quintero, Meharji Arumilli, Geoffray Monteuuis, Jonas Donner, Marjukka Anttila, Anu Suomalainen, Laurence A Bindoff, Hannes T Lohi
In-frame deletion in canine PITRM1 is associated with a severe early-onset epilepsy, mitochondrial dysfunction and neurodegeneration. Human genetics 140 (11) (2021)
Riikka Havunen, Riikka Kalliokoski, Mikko Siurala, Suvi Sorsa, João M Santos, Victor Cervera-Carrascon, Marjukka Anttila, Akseli Hemminki
Cytokine-Coding Oncolytic Adenovirus TILT-123 Is Safe, Selective, and Effective as a Single Agent and in Combination with Immune Checkpoint Inhibitor Anti-PD-1. Cells 10 (2) (2021)
Kati J Dillard, Matthias Ochs, Julia E Niskanen, Meharji Arumilli, Jonas Donner, Kaisa Kyöstilä, Marjo K Hytönen, Marjukka Anttila, Hannes T Lohi
Recessive missense LAMP3 variant associated with defect in lamellar body biogenesis and fatal neonatal interstitial lung disease in dogs. PLoS genetics 16 (3) (2020)
Kati J Dillard, Marjo K Hytönen, Daniel Fischer, Kimmo Tanhuanpää, Mari S Lehti, Katri Vainio-Siukola, Anu Sironen, Marjukka Anttila
A splice site variant in INPP5E causes diffuse cystic renal dysplasia and hepatic fibrosis in dogs. PloS one 13 (9) (2018)

Marjukka Anttila.css-eqlu8i{font-size:small;padding-left:4px;} (M Anttila)

Publication Activity (10 Years)

Top Topics

Top Venues

Marjukka Anttila (M Anttila)